Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TCR2 THERAPEUTICS INC. | Chief Scientific Officer | Common Stock | 45.9K | $78.9K | $1.72 | Dec 9, 2021 | Direct |
TCR2 THERAPEUTICS INC. | Chief Scientific Officer | Stock Option (Right to Buy) | 100K | $74K | $0.74 | Dec 9, 2021 | Direct |
Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 12.8K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
TCRT | Alaunos Therapeutics, Inc. | Mar 30, 2023 | 2 | $0 | 4 | Apr 19, 2023 | Director |
TCRT | Alaunos Therapeutics, Inc. | Mar 30, 2023 | 0 | $0 | 3 | Apr 19, 2023 | Director |
TCRR | TCR2 THERAPEUTICS INC. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Chief Scientific Officer |